Arlington Trust’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$90.5K Buy
1,157
+120
+12% +$9.68K 0.01% 195
2026
Q1
$89.9K Hold
1,037
0.01% 177
2025
Q4
$99.6K Sell
1,037
-702
-40% -$68.2K 0.01% 140
2025
Q3
$166K Buy
1,739
+876
+102% +$80.5K 0.03% 200
2025
Q2
$75.2K Hold
863
0.01% 304
2025
Q1
$77.5K Sell
863
-794
-48% -$71K 0.02% 306
2024
Q4
$132K Buy
1,657
+794
+92% +$68.7K 0.03% 229
2024
Q3
$77.7K Hold
863
0.02% 286
2024
Q2
$67.9K Buy
863
+36
+4% +$2.95K 0.02% 298
2024
Q1
$72.1K Sell
827
-15
-2% -$1.28K 0.02% 253
2023
Q4
$69.4K Buy
+842
New +$64.2K 0.02% 255

Other funds holding MDT

Arlington Trust's MDT Position: Q2 2026 in Review

Arlington Trust increased its Medtronic (MDT) stake by 12% in Q2 2026, buying an estimated $9.68K and bringing the position to 1,157 shares worth $90.5K. The position accounts for 0.01% of the portfolio, ranked #195.

Arlington Trust first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $166K in Q3 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Arlington Trust held 1,157 shares of Medtronic worth $90.5K as of Q2 2026.
  • Arlington Trust bought 120 Medtronic shares in Q2 2026, an estimated $9.68K.
  • Medtronic made up 0.01% of Arlington Trust's portfolio in Q2 2026, its #195 holding.
  • Arlington Trust first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • Arlington Trust's Medtronic position peaked at $166K in Q3 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.